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BRIEF COMMUNICATION
Trypanosoma cruzi PARASITEMIA OBSERVED IN IMMUNOCOMPROMISED PATIENTS: THE
IMPORTANCE OF THE ARTIFICIAL XENODIAGNOSIS
Lúcia Maria Almeida BRAZ, Vicente AMATO NETO, Fábio Luiz CARIGNANI & Cláudia Regina De MARCHI
SUMMARY
Trypanosoma cruzi parasitemia observed in immunocompromised patients (transplant or positive HIV) occurred more frequently
by the artificial xenodiagnosis method (10/38) compared with hemoculture (2/38), given the same quantity of blood. Other ways of
diagnosis, like mice inoculation (5/38), QBC and buffy coat (2/38), were evaluated also. This result showed the importance of the
artificial xenodiagnosis. The other techniques increased only one more patient positive.
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Through xenodiagnosis – the most commonly used demonstration
method of Trypanosoma cruzi – the feces and the triatomine intestine
content, of third and fourth stages, gotten through compression or
dissection are examined under optical microscopy, respectively, 30 and
60 days after feeding on patient’s blood. This method demands the
availability of triatomine which is free of infection, created in the lab
and fed on bird’s blood that is refractory to infection. A positivity of
49.3% was already reached with patients having chronic Chagas disease2.
The T. cruzi is a flagellated protozoan easily cultured in acellular
media that contain hemin derivates. The hemoculture technique got
credibility when CHIARI & BRENER, in 1966, got 31.8% of positivity
using the LIT medium, bringing new possibilities3 . MOURÃO &
MELLO, in 1975, developed a process for removing plasma and washing
the cells to remove the antibodies or other factors that could apparently
inhibit growth of T. cruzi7.
The concomitant use of hemoculture and of artificial xenodiagnosis
for Chagas disease diagnosis must be considered following those
recommendations given by the aforementioned researchers, as long as
the spoliation of patient’s blood – many times extremely weakened when
submitted to an immunosuppressive condition – does not take place. In
order to investigate the xenodiagnosis sensitivity10 against the
hemoculture using lesser blood volume and removing the plasma, we
decided to perform this study using an equal blood volume for each
technique. Besides these two, we added the buffy coat, the QBC
(Quantitative Buffy Coat) and the inoculation in mice.
The exams were performed using approximately 12 ml of blood of
each of the 71 samples coming from 38 patients known to have the
chronic Chagas disease and immunosuppressed related to either a
transplant or to the human immunodeficiency virus (HIV). We received
1 to 4 samples from each patient. The exceptions were 2 patients who
gave 7 and 10 samples.
In order to perform the artificial xenodiagnosis, we submitted 20
triatomines to feeding in 5 ml of blood, having the anticoagulant sodium
citrate pre-heated to 37 °C for 45 minutes, coming from a patient
immediately upon his arrival at the lab. After 30 and 60 days, respectively,
we examined the feces and the intestinal content of the insects2.
The remaining 5 ml volume collected aseptically was centrifuged at
3500 rpm, for 20 minutes, at 4 °C, immediately upon its arrival at the
lab, too. After such a period, we took the plasma and seeded the sediment
in 4 ml of the LIT medium. After 30 days, we examined in an optical
microscope half of the media, that is approximately 3 ml, in the following
way: through a direct examination of 10 l of the media and 10 l after
centrifugation, at 3,500 rpm, for 10 minutes. The same procedure was
repeated after 60 days with the remaining volume.
With the remaining blood we performed the following: 1) buffy coat:
50 l of blood collected in a capillary tube was submitted to centrifugation
at 3,500 rpm, for 15 minutes; after such a period, we cut the tube and
examined a drop of the material in an optical microscope; 2) QBC
(Quantitative Buffy Coat): 60 l of blood collected in a capillary tube

BRAZ, L.M.A.; AMATO NETO, V.; CARIGNANI, F.L. & DE MARCHI, C. R. - Trypanosoma cruzi parasitemia observed in immunocompromised patients: the importance of the artificial
xenodiagnosis. Rev. Inst. Med. trop. S. Paulo, 43(2): 113-115, 2001.
internally coated by acridine orange and anticoagulant; after the
centrifugation at 12,000 rpm, for 5 minutes, we examined the tube directly
at the fluorescence microscope; and 3) inoculation of approximately
0.5 ml of blood in each of the two Balb/C mice, who had their blood
examined weekly, for 2 months.
From the 38 patients examined, 10 (26.3%) were positive in the
artificial xenodiagnosis, only 1 in the second examination (60 days).
Five (13.1%) in the inoculation of the mice; the same positive in the
xenodiagnosis. The hemoculture was positive only in 2 cases (5.2%);
only one positive sample was found using this technique. The buffy coat
and the QBC were also found positive in only 2 samples: the first one
when all the other techniques were positive, and the second one only
when the artificial xenodiagnosis was positive (Table 1).
The need to perfect new techniques is ever growing allowing us to
appraise the reactivation of Chagas disease through observation of the
parasite, in immunosuppressive situations by drug therapy in transplanted
patients1 and in patients infected by HIV10. SARTORI, in 1998, said the
parasitemia is more frequent and higher in the amount of infected and
immunosuppressed patients than those described for chronic
immunocompetent patients10, since the xenodiagnosis using 40 bugs was
positive in 81.25% of the first group.
Comparing the hemoculture and the artificial xenodiagnosis using
the same blood volume – that is, 5 milliliters for each, which is a
reasonable volume gotten from patients already extremely debilitated –
the second technique was seen to be superior (26.3%); 5 patients were
positive exclusively by this technique, even when using only 20
triatomines. The use of 40 triatomines1,2 is generally recommended.
CHIARI & DIAS, in 1975, developed a pilot project in which the total
blood volume for the hemoculture was increased from 10 ml to 30 ml to
improve the sensitivity. They got a positivity of 30% and 50%,
respectively, with the xenodiagnosis and the hemoculture in a group of
40 patients4. CREMA et al., in 1996, and SILVA et al., in 1996, have
demonstrated that even with a higher blood volume used in the
hemoculture, the positivity ratio was similar to the xenodiagnosis5, 11. In
another study, using the same blood volume, the xenodiagnosis was
higher: 36% of positive tests by xenodiagnosis and 9.6% by hemoculture6.
Hemoculture is still quite labor intensive.
The essence of this study was that a reduced volume of blood was
necessary for the two techniques and a lesser amount of insects than
what is commonly professed. Also, the results point out an order of
importance between the techniques; xenodiagnosis, followed by the
inoculation in mice. The hemoculture, the QBC and the buffy coat
presented approximate positivity figures.
After more than 80 years, xenodiagnosis is still ahead of the other
classical tests, when dealing with detection of the parasitemia. The
artificial xenodiagnosis has the advantage of being more comfortable
for the patient with Chagas disease and under immunosuppression,
eliminating eventual allergic reactions deriving from the triatomine bite,
and allowing repetition of the tests with greater facility8. Therefore, while
we wait for more concrete recommendations as for the use of a molecular
technique such as the Polymerize Chain Reaction (PCR), the
xenodiagnosis that depends on triatomine remains preferred as does the
entire structure for the method’s maintenance, costing to the Brazilian
Health System known as “SUS” (Sistema Único de Saúde) $30 Brazilian
Reals, with 40 triatomines9 and which is easy to perform.
RESUMO
A importância do xenodiagnóstico artifical no diagnóstico da
parasitemia pelo Trypanosoma cruzi em pacientes
imunocomprometidos
A demonstracão da parasitemia pelo Trypanosoma cruzi em pacientes
imunocomprometidos (transplantados ou HIV positivos) ocorreu com
mais frequência por meio do xenodiagnóstico (10/38) frente à
hemocultura (2/38), quando se utilizou o mesmo volume de sangue.
Também foram avaliados outros métodos de diagnóstico como inoculação
Table 1
Eleven positive cases in at least one of this five diagnosis techniques applied among 71 blood samples from 38 immunosuppressed chagasics
Patient Buffy coat QBC Hemoculture Inoculation Xenodiagnosis
(number of the (30 and 60 days) in mice (30 and 60 days)
samples collected (number of the
from each patient) positive sample)
BSQ (1 S) – – – – + (30 and 60)
CJAJ (2 S) – – – + + (60)  (1st S)
MCS (1 S) – – – + + (30 and 60)
SMC (1 S) – – – – + (30 and 60)
ICM (1 S) – – – – + (30 and 60)
MTG (1 S) – – + (60) – –
JSS (1 S) – – – + + (30 and 60)
DD (2 S) – – – – + (30 and 60)  (1st S)
JSV (3 S) – – – – + (30 and 60)  (2nd S)
APG (10 S) + + – + + (30 and 60)  (3rd S)
JCC (AIDS) (1 S) + + + (30 and 60) + + (30 and 60)
S: Sample; +: Positive; –: Negative
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em camundongos (5/38), QBC e creme leucocitário (2/38). Este resultado
reitera a importância do xenodiagnóstico artificial. As outras técnicas
acrescentaram apenas mais um paciente positivo.
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